|
Wednesday, November 15, 2023
Print Current Session:
 |
|
|
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Location: Grand Ballroom East, 3rd Floor
Moderators:TBD |
|
| SESSION 24 SCHEDULE | |
| PROGRESS IN ATHERECTOMY | |
| 7:53 AM - 7:58 AM | New Developments In Laser Atherectomy And Lithotripsy: What Progress Has Been Made And Are Their Benefits Proven |
|
Presenter(s):George L. Adams, MD Location: Grand Ballroom East, 3rd Floor |
|
| 7:59 AM - 8:04 AM | Which Vascular Specialists Are Performing Tibial Atherectomies And Angioplasties For Intermittent Claudication And Are There Suboptimal Outcomes |
|
Presenter(s):Caitlin W. Hicks, MD, MS Location: Grand Ballroom East, 3rd Floor |
|
| 8:05 AM - 8:10 AM | Update On Optical Coherence Tomography (OCT) Guided Intraluminal Crossing And Atherectomy (Pantheris) For Long Total SFA Occlusions: Superiority Over Other Techniques That Use Subintimal Crossing |
|
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor |
|
| 8:11 AM - 8:16 AM | 2-Year Experience With The Rotarex Atherectomy And Thrombectomy System (From BD) For Arterial Occlusive Disease And In Stent Restenosis (ISR): How Does It Work And Advantages |
|
Presenter(s):Michael K.W. Lichtenberg, MD Location: Grand Ballroom East, 3rd Floor |
|
| UPDATE ON THE SUPERA STENT | |
| 8:17 AM - 8:23 AM | Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First |
|
Presenter(s):Peter C.J. Goverde, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:23 AM - 8:28 AM | Update On The Supera Interwoven Stent: When Is It The Best Treatment And How To Optimally Deploy This Unique Stent |
|
Presenter(s):D. Christopher Metzger, MD / Craig M. Walker, MD Location: Grand Ballroom East, 3rd Floor |
|
| DRUG ELUTING STENTS (DESs) FOR BTK LESIONS | |
| 8:29 AM - 8:34 AM | Updated Experience With Everolimus And Other Nonabsorbable DESs To Treat Infrapopliteal BTK Lesions – Long And Short - Causing CLTI: What Are The Stents And How Are They Doing |
|
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor |
|
| 8:35 AM - 8:40 AM | Update On Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5 Years: From The DISAPEAR Registry And A Meta-Analysis Of Other Bioresorbable BTK Stent Results |
|
Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) Location: Grand Ballroom East, 3rd Floor |
|
| 8:41 AM - 8:46 AM | Progress In And Early Results Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Stent With Plain Balloon Angioplasty (POBA) |
|
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:47 AM - 8:52 AM | Updated Results With A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: From The STAND RCT And The HEAL Registry |
|
Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI / Marco G. Manzi, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:53 AM - 9:00 AM | Panel Discussion |
| END OF SESSION 24 | |
| previous | next |